The estimated Net Worth of Co., Llc Bfi is at least $57 millió dollars as of 12 September 2018. Co Bfi owns over 520 units of Phibro Animal Health stock worth over $1,216,366 and over the last 11 years Co sold PAHC stock worth over $55,790,520.
Co has made over 68 trades of the Phibro Animal Health stock since 2014, according to the Form 4 filled with the SEC. Most recently Co sold 520 units of PAHC stock worth $23,421 on 12 September 2018.
The largest trade Co's ever made was selling 223,075 units of Phibro Animal Health stock on 1 August 2014 worth over $4,575,268. On average, Co trades about 21,471 units every 21 days since 2014. As of 12 September 2018 Co still owns at least 59,480 units of Phibro Animal Health stock.
You can see the complete history of Co Bfi stock trades at the bottom of the page.
Co's mailing address filed with the SEC is 300 FRANK W. BURR BLVD., STE 21, , TEANECK, NJ, 07666-6712.
Over the last 11 years, insiders at Phibro Animal Health have traded over $195,476,671 worth of Phibro Animal Health stock and bought 26,000 units worth $514,940 . The most active insiders traders include L.P. Mayflower, Co., Llc Bfi és Jack Bendheim. On average, Phibro Animal Health executives and independent directors trade stock every 17 days with the average trade being worth of $962,991. The most recent stock trade was executed by E Thomas Corcoran on 4 September 2024, trading 5,000 units of PAHC stock currently worth $100,100.
phibro animal health corporation is a leading global diversified animal health and mineral nutrition company. we are dedicated to helping meet the growing demand for animal protein. we concentrate exclusively on animals for food production and are one of the few global companies offering a comprehensive range of animal health and mineral nutrition products. for over 40 years we have been committed to providing livestock producers with value-based products and solutions to help them maintain and enhance the health of their animals. we develop, manufacture and market a broad range of products for food animals including poultry, swine, beef and dairy cattle and aquaculture. our products help prevent, control and treat diseases, enhance nutrition to help improve health and contribute to balanced mineral nutrition. phibro animal health corporation reported net sales of $764 million for the fiscal year ended june 30, 2017. our more than 1,400 employees are proud to manufacture and market our
Phibro Animal Health executives and other stock owners filed with the SEC include: